Medtronic PLC has closed the acquisition of software company Klue, which will add new technology for use in the medical-device maker's automated insulin pump system.

The personalized closed loop pump system automates insulin delivery in patients. Medtronic intends to use Klue's technology to give real-time insights into a person's food consumption so that the PCL system can adapt to users in real-time. The technology will also be used in Medtronic's glucose management system to schedule patients' doses.

Medtronic's PCL system, several models of which were recalled in June due to cybersecurity vulnerabilities, won a breakthrough designation from the U.S. Food and Drug Administration in February.

Financial details of the acquisition were not disclosed in a Dec. 17 press release announcing the deal's closure.

Dublin-based Medtronic develops and distributes device-based medical therapies to hospitals, physicians, clinicians and patients.